FDA Patient Listening Sessions: FDA Staff Reflections: Lewis Fermaglich

preview_player
Показать описание
Lewis Fermaglich from FDA’s Office of Orphan Products Development describes an impact of the FDA Patient Listening Session program.
Рекомендации по теме